Thank you all for your prompt and very helpful responses. I read all of them very attentively. Something that maybe was not clear for everybody from my first email is that the exoskeleton is definitely a medical device as it is intended for lower limbs impairments and indeed we have already FDA clearance and CE mark under MDR.
Concerning the idea of asking for feedback to the FDA, I have already written to DICE and waiting for an answer. I initially discarded 513g because of the cost, but it is definitely a good option. Also I agree with Leonard concerning the need of applying some of the clauses of 60601-1, labeling, risk analysis and GMP (as far as applicable).
I have also analyzed the mechanical chair and the assistive device CFR regulations, recommended by Anne, but I feel both of them are intended to help patients in movements and activities (e.g., crutches, walkers, etc.) while in our case the seat is used exclusively to make the device stand-up and sit down (see an image below as example). Ideally we would like to use it as well to transport the exoskeleton (without patient), which is the reason of the wheels, but we will make very clear that it should not be used to transport the exoskeleton with the patient inside. And if the wheels create additional burden (as they may create confusion with wheelchairs) I will probably recommend the R&D team to avoid them.
We will claim the very minimum. The real purpose is to respond to a user need (today hard to find in the market) and not to promote a real medical device accessory. I see the intended use of the exoskeleton as walking, gait assistance, and physical rehabilitation, none of which is "enabled" or "assisted" by the chair. I am also happy to hear any recommendation you may have on wording to avoid to make clear that the chair is not a medical device nor an accessory.
Thanks again for the fruitful discussion. I appreciate.
------------------------------
Maria Ida Iacono
Paris
France
------------------------------
Original Message:
Sent: 28-Mar-2023 11:12
From: Maria Ida Iacono
Subject: medical furniture classification and requirements - US and EU
Hi all,
We are a medical device company that produces exoskeletons for patients with lower limbs impairments. Our R&D team is working on the design of a manually operated chair with wheels that can be used for two purposes:
- as a starting point for the exoskeleton (and the patient inside it) to stand-up at the beginning of a session. The patient is installed in the exoskeleton in seated position. Chairs need to meet specific requirements in terms of weight to be hold (patient + device), height, width, etc. and today we did not manage to find one that suits well our needs and that we can recommend to clients.
- to transport the exoskeleton (without the patient) in the rehab center from one room to another (similar to a cart).
We see this chair like a piece of furniture and not a medical device nor an accessory to a medical device. Please note that the chair should not be confused with a wheelchair and we don't intend to use it to aid the locomotion of the patient. The presence of wheels has the only purpose of make the chair more manageable and to facilitate the transport of the medical device (the exoskeleton) across the rehab facility.
I am struggling to find info on how to classify this device both for US and EU, whether we should apply specific regulations in US or directives in EU or specific standards. We currently hold a 510k and CE mark under MDR for the device.
Any comment or insight would be highly appreciated.
Thanks in advance
Maria
------------------------------
Maria Iacono, PhD
Paris
France
------------------------------